AveXis, Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY17 | FY16 | FY15 | |
|---|---|---|---|
| Revenue | — | — | — |
| Operating income | −$30.0M | −$20.9M | −$38.6M |
| Net income | −$29.7M | −$20.8M | −$38.5M |
| Total assets | $391.6M | $270.6M | $65.1M |
| Total liabilities | $58.8M | $24.4M | $6.9M |
| Equity | $332.7M | $246.1M | $57.2M |
| EPS (diluted) | — | — | — |
| Shares out. | 27.7M | 27.7M | 6.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2017- Operating margin
- —
- Net margin
- —
- Return on equity
- −8.9%
- Return on assets
- −7.6%
- Return on capital (ROCE)
- −9.0%
- Liabilities / assets
- 15.0%
- Debt / equity
- 0.18×
- Book value / share
- $12.00
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2017- Altman Z″ (distress)
- 7.02safe
- Accruals / assets
- 32.6%high accruals
- Piotroski F-Score
- 1/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 warning● 2 good- Negative operating cash flow
- High accruals — earnings-quality risk
- Conservative leverage (liabilities < 50% of assets)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsMay 15, 2018
- Results of operationsMay 3, 2018
- Other material eventApr 25, 2018
- Other material eventApr 24, 2018
- Entered a material agreement · Amended charter or bylaws · Other material eventApr 9, 2018
- Other material eventMar 27, 2018
- Entered a material agreement · Regulation FD disclosureMar 13, 2018
- Results of operations · Regulation FD disclosureFeb 27, 2018
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AJun 11, 2018
- CT ORDERJun 6, 2018
- 15-12BJun 4, 2018
- EFFECTMay 22, 2018
- SC 13D/AAVEXIS, INC.May 17, 2018
- CT ORDERMay 16, 2018
- 3May 15, 2018
- 4FORM 4 SUBMISSIONMay 15, 2018
- 4FORM 4 SUBMISSIONMay 15, 2018
- 4FORM 4 SUBMISSIONMay 15, 2018
- 4FORM 4 SUBMISSIONMay 15, 2018
- 4FORM 4 SUBMISSIONMay 15, 2018
- 4FORM 4 SUBMISSIONMay 15, 2018
- 4FORM 4 SUBMISSIONMay 15, 2018
- 4FORM 4 SUBMISSIONMay 15, 2018
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.